Related Experiment Videos
[Management of pediatric asthma]
R Cristofori1, P Solidoro, M S Magnoni
1Dipartimento di Fisiopatologia Clinica, Università degli Studi di Torino, Torino, Italy.
Minerva Pediatrica
|November 11, 2003
Summary
Asthma is a widespread respiratory condition often poorly controlled. Early intervention with inhaled corticosteroids, potentially combined with long-acting beta2-agonists, improves asthma management and long-term outcomes.
Area of Science:
- Respiratory Medicine
- Clinical Pharmacology
Context:
- Bronchial asthma affects 4-7% of the population in Western Europe, presenting a significant public health challenge.
- Studies indicate poor asthma control in Italy, characterized by frequent symptoms, daily activity limitations, and high healthcare resource utilization.
Purpose:
- To highlight the importance of early intervention with anti-inflammatory drugs for preventing irreversible airway changes and improving long-term prognosis in children and adults.
- To emphasize the synergistic role of combination therapy in managing severe asthma.
Summary:
- Current guidelines (GINA, NIH) recommend inhaled corticosteroids as the primary treatment for asthma control.
- For severe asthma, combining inhaled corticosteroids with long-acting beta2-agonists offers synergistic benefits by addressing both inflammation and bronchial obstruction.
- This combination therapy optimizes pharmacological activity for more effective asthma control.
Impact:
- Improved asthma management through evidence-based treatment strategies.
- Potential reduction in healthcare resource utilization associated with poorly controlled asthma.
- Enhanced long-term prognosis for individuals with asthma, particularly when treated early.